ACVRL1 and atherosclerosis: With recent evidence showing that ALK1 depletion reduces atherosclerosis in mice, and two ALK1 molecules in each BMP9-signalling complex, a testable, plausible explanation can be proposed based on dominant negative activity further reducing ALK1 function.